Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

Market Cap	18.38B +5.6%
Revenue (ttm)	1.89B +14.2%
Net Income	383.13M +144.8%
EPS	0.65 +144.1%
Shares Out	n/a
PE Ratio	47.97
Forward PE	44.18
Dividend	0.46 (1.51%)
Ex-Dividend Date	Dec 3, 2025

Volume	380,507
Average Volume	416,547
Open	31.22
Previous Close	30.93
Day's Range	31.22 - 31.88
52-Week Range	29.58 - 35.31
Beta	0.93
RSI	45.78
Earnings Date	May 28, 2026

About ASX:FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,440
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In fiscal year 2025, ASX:FPH's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.

Financial numbers in NZD